Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors


    EXCEL SPREADSHEET?, 21 CFR 11,FDA RECOMMENDATIONS, 2012 - Live webinar on Excel Spreadsheet Compliance with 21 CFR 11 By Compliance2go

    View: 323

    Website https://compliance2go.com/index.php?option=com_training&speakerkey=13&productKey=28 | Want to Edit it Edit Freely

    Category FDA Compliant,(GLP),Biologics,Biosimilars,Drugs, (SOPs),(ASQ),(RAC), QAU,

    Deadline: August 02, 2012 | Date: August 02, 2012

    Venue/Country: houston, U.S.A

    Updated: 2012-07-04 01:56:29 (GMT+9)

    Call For Papers - CFP

    This course will describe the regulatory and business requirements for Excel spreadsheets, using examples from FDA recommendations. It will then cover the design and installation of those Excel Spreadsheets, to ensure the integrity of the data, and will discuss how to ensure 21 CFR 11 compliance during the development, installation and maintenance of a spreadsheet application.

    Why should you Attend

    Spreadsheet Applications such as MS Excel are frequently used in 21 CFR 11 compliant environments, but they were not specifically designed for regulated environments and their development is not optimized for 21 CFR 11 compliance. However, the FDA expects that spreadsheets be compliant and lack of compliance can result in a warning letter. Consequently, validation of Excel Spreadsheet Applications is required as part of a 21 CFR 11 compliant environment.

    Areas Covered in the Session

    1. Requirements for Excel Spreadsheets

    2. FDA Part 11 Validation Guidance

    3. Compliance Problems with Spreadsheets

    4. Design Specifications for 21 CFR 11 compliance

    5. How does the FDA Design and Use spreadsheets

    6. Documentation for Part 11

    7. Future Trends in 21 CFR 11 compliance for Excel Spreadsheets

    Webinar Includes:

    Q/A Session with the Expert to ask your question

    PDF print only copy of PowerPoint slides

    90 Minutes Live Presentation

    Who will Benefit

    Quality Managers

    Quality Engineers

    Small business owners

    Internal and external auditors

    Management Reps

    FDA inspectors

    Consultants

    About Speaker

    Angela Bazigos has been accepted into the prestigious ranks of Stanford Who’s Who as a result of her remarkable work in the biotechnology industry. Throughout her brilliant professional career, Angela has routinely exhibited the passion, vision and dedication necessary to be successful in the business world.

    Angela Bazigos is the CEO of Touchstone Technologies Silicon Valley, Inc. “Your Passport to Compliance”. She has 30 years experience in the Life Sciences industry spanning project management, Quality Assurance and Regulatory Affairs. She has applied for patents aimed at speeding up Software Compliance and FDA Audits.

    Angela is a member SQA (Society of Quality Assurance) as well as of the SQA CVIC (Computer Validation Initiative Committee), DIA and RAPS. She provides consulting services to Pharma, Biotech, Medical Device and CRO industries on compliance matters, including strategy, submissions, quality assurance, computer systems validation, and remediation’s following action by the FDA. She also teaches classes on Compliance, 21 CFR 11, Computer Systems Validation, and Project Management.

    More recently, Ms. Bazigos co-authored Computerized Systems in Clinical Research, Current Data Quality and Data Integrity Concepts with FDA, DIA and Academia. She is also on the board for UC Berkeley’s Haas Business School for Executive Education in Life Sciences.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.